AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 265: E176-E178, 1993;
0193-1849/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maltin, C. A.
Right arrow Articles by Hesketh, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maltin, C. A.
Right arrow Articles by Hesketh, J. E.

AJP - Endocrinology and Metabolism, Vol 265, Issue 1 E176-E178, Copyright © 1993 by American Physiological Society

ARTICLES

Clenbuterol mimics effects of innervation on myogenic regulatory factor expression

C. A. Maltin, M. I. Delday, G. P. Campbell and J. E. Hesketh
Rowett Research Institute, Bucksburn, Aberdeen, Scotland.

The amelioration of denervation atrophy by the beta-adrenoceptor agonist clenbuterol has led to the suggestion that the drug mimics or stimulates production of neurotrophic factors. Neurotrophic factors have profound effects on muscle growth, but the precise mechanisms through which this influence is exerted are unknown. The expression of myoD and myogenin, proteins that in turn regulate the transcription of tissue-specific genes during skeletal muscle differentiation, is controlled by innervation. In muscle undergoing denervation-induced atrophy, myoD and myogenin mRNAs increase. However, this is only partially reversed by electrical activity, thus implicating neurotrophic factors in regulation of these genes. Here we demonstrate that clenbuterol represses myoD and myogenin expression and decreases the levels of acetylcholine receptors in denervated muscles. The data provide the first evidence that the action of clenbuterol is directed through the neural axis.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. A. Sneddon, M. I. Delday, J. Steven, and C. A. Maltin
Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70S6k in muscle showing clenbuterol-induced anabolism
Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E676 - E682.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. A. Sneddon, M. I. Delday, and C. A. Maltin
Amelioration of denervation-induced atrophy by clenbuterol is associated with increased PKC-alpha activity
Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E188 - E195.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
P. E. Mozdziak, M. L. Greaser, and E. Schultz
Myogenin, MyoD, and myosin expression after pharmacologically and surgically induced hypertrophy
J Appl Physiol, April 1, 1998; 84(4): 1359 - 1364.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online